Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
September 09, 2021 at 14:30 PM EDT
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.